Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2012 Nov 21:13:219.
doi: 10.1186/1745-6215-13-219.

The effect of a patient-oriented treatment decision aid for risk factor management in patients with diabetes (PORTDA-diab): study protocol for a randomised controlled trial

Affiliations
Randomized Controlled Trial

The effect of a patient-oriented treatment decision aid for risk factor management in patients with diabetes (PORTDA-diab): study protocol for a randomised controlled trial

Petra Denig et al. Trials. .

Abstract

Background: To improve risk factor management in diabetes, we need to support effective interactions between patients and healthcare providers. Our aim is to develop and evaluate a treatment decision aid that offers personalised information on treatment options and outcomes, and is intended to empower patients in taking a proactive role in their disease management. Important features are: (1) involving patients in setting goals together with their provider; (2) encourage them to prioritise on treatments that maximise relevant outcomes; and (3) integration of the decision aid in the practice setting and workflow. As secondary aim, we want to evaluate the impact of different presentation formats, and learn more from the experiences of the healthcare providers and patients with the decision aid.

Methods and design: We will conduct a randomised trial comparing four formats of the decision aid in a 2 × 2 factorial design with a control group. Patients with type 2 diabetes managed in 18 to 20 primary care practices in The Netherlands will be recruited. Excluded are patients with a recent myocardial infarction, stroke, heart failure, angina pectoris, terminal illness, cognitive deficits, > 65 years at diagnosis, or not able to read Dutch. The decision aid is offered to the patients immediately before their quarterly practice consultation. The same decision information will be available to the healthcare provider for use during consultation. In addition, the providers receive a set of treatment cards, which they can use to discuss the benefits and risks of different options. Patients in the control group will receive care as usual. We will measure the effect of the intervention on patient empowerment, satisfaction with care, beliefs about medication, negative emotions, health status, prescribed medication, and predicted cardiovascular risk. Data will be collected with questionnaires and automated extraction from medical records in 6 months before and after the intervention.

Discussion: This decision aid is innovative in supporting patients and their healthcare providers to make shared decisions about multiple treatments, using the patient's data from electronic medical records. The results can contribute to the further development and implementation of electronic decision support tools for the management of chronic diseases.

Trial registration: Dutch Trial register NTR1942.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flowchart of the PORTDA-diab study.
Figure 2
Figure 2
Practice randomisation scheme.
Figure 3
Figure 3
Patient’s current situation and treatment status. Brief overview of information collected from the electronic medical record showing the patient’s current situation and treatment.
Figure 4
Figure 4
Bar graph showing the patient’s risk of getting a myocardial infraction. Shown are the patient’s current 5-year risk, the expected risk when goals are achieved for all risk factors, and the risk of a similar person without diabetes.
Figure 5
Figure 5
Bar graph showing the patient’s possible risk reductions for each risk factor with accompanying questions. Shown are the patient’s possible risk reduction when all or each of the separate risk factors would reach the recommended target values. Below the graph the accompanying questions asked in the decision aid are presented.
Figure 6
Figure 6
Example of treatment cards.

References

    1. American Diabetes Association. Standards of medical care in diabetes--2012. Diabetes Care. 2012;Suppl 1:S11–63. - PMC - PubMed
    1. Guthrie B, Emslie-Smith A, Morris AD. Which people with type 2 diabetes achieve good control of intermediate outcomes? Population database study in a UK region. Diabet Med. 2009;26:1269–1276. doi: 10.1111/j.1464-5491.2009.02837.x. - DOI - PubMed
    1. Sidorenkov G, Haaijer-Ruskamp FM, de Zeeuw D, Denig P. A longitudinal study examining adherence to guidelines in diabetes care according to different definitions of adequacy and timeliness. PLoS One. 2011;6:e24278. doi: 10.1371/journal.pone.0024278. - DOI - PMC - PubMed
    1. Renders CM, Valk GD, Griffin SJ, Wagner E, van Eijk JT, Assendelft WJJ. Interventions to improve the management of diabetes mellitus in primary care, outpatient and community settings. Cochrane Database Syst Rev. 2000;4:CD001481. - PMC - PubMed
    1. Norris SL, Engelgau MM, Narayan KM. Effectiveness of self-management training in type 2 diabetes: a systematic review of randomized controlled trials. Diabetes Care. 2001;24:561–587. doi: 10.2337/diacare.24.3.561. - DOI - PubMed

Publication types